Evidence-Based Ways to Improve Your Continuous Glucose Monitor (CGM) Numbers

Medical lab testing image for Evidence-Based Ways to Improve Your Continuous Glucose Monitor (CGM) Numbers

At a glance

  • Target range for most adults / 70 to 180 mg/dL (ADA/AACE consensus)
  • Time-in-range goal / ≥70% of readings in 70 to 180 mg/dL
  • Time below range goal / <4% of readings below 70 mg/dL
  • Time above range goal / <25% of readings above 180 mg/dL
  • Coefficient of variation target / ≤36% indicates stable glycemia
  • A 5% TIR increase / corresponds to roughly 0.5% HbA1c reduction
  • Exercise effect / 30 min post-meal walking can cut glucose spikes by 30 to 50%
  • Sleep deficit impact / one night of 4-hour sleep raises next-day glucose by 15 to 25%
  • CGM accuracy / most devices have MARD of 8 to 10%

What a CGM Actually Measures and Why It Matters

A continuous glucose monitor is a small sensor, usually worn on the upper arm or abdomen, that samples interstitial glucose every 1 to 5 minutes and transmits readings to a receiver or smartphone. Unlike a single fasting blood draw, CGM captures the full 24-hour glucose profile: post-meal spikes, overnight dips, dawn phenomenon, and the effects of exercise in real time.

Interstitial vs. Blood Glucose

CGM sensors measure glucose in the interstitial fluid, not directly in blood. There is a physiological lag of roughly 5 to 15 minutes between a blood glucose change and its reflection in interstitial readings 1. This lag matters most during rapid glucose shifts, such as immediately after a high-carbohydrate meal or intense exercise. Modern sensors like the Dexcom G7 and Abbott FreeStyle Libre 3 achieve a mean absolute relative difference (MARD) of approximately 8.2 to 9.0%, meaning they track blood glucose closely enough for clinical decision-making 2.

Why Time-in-Range Replaced Averages

The 2019 International Consensus on Time in Range, published in Diabetes Care, established that average glucose alone is misleading 3. Two people can share the same average of 140 mg/dL while one spends 80% of the day in range and the other swings between 60 and 280. The consensus panel, representing the ADA, EASD, AACE, and the Endocrine Society, recommended that adults with type 1 or type 2 diabetes target TIR ≥70%, time below range (TBR) <4%, and time above range (TAR) <25%. For older adults or those at high hypoglycemia risk, TIR ≥50% is acceptable.

A 2020 analysis in Diabetes Care confirmed that each 5-percentage-point increase in TIR corresponds to a clinically meaningful 0.5% reduction in HbA1c 4.

Dietary Strategies That Move CGM Numbers

Food composition, sequencing, and timing exert the single largest influence on post-meal glucose excursions. The following approaches have direct CGM-verified evidence.

Macronutrient Sequencing

A 2015 study by Shukla et al. In Diabetes Care (N=16, crossover design) found that eating protein and vegetables before carbohydrates reduced the 2-hour post-meal glucose incremental area under the curve by 73% compared with eating carbohydrates first 5. A follow-up trial (N=16) confirmed similar results with a 30-minute protein-first window in outpatient settings. Pairing carbohydrates with fat and fiber slows gastric emptying and blunts the glucose spike. This costs nothing and requires no medication change.

Carbohydrate Quality and Quantity

The glycemic index concept has limitations, but replacing refined grains with whole grains consistently reduces post-meal CGM spikes. A 2021 randomized crossover trial (N=24) published in The American Journal of Clinical Nutrition showed that substituting white bread with whole-grain sourdough bread reduced the 2-hour glucose AUC by 25% on CGM 6. Portion size matters independently: reducing carbohydrate load from 60 g to 30 g at a single meal typically cuts the peak glucose excursion by 40 to 60%.

Meal Timing and Circadian Alignment

Glucose tolerance deteriorates across the day. A 2022 study in Diabetologia (N=845) using CGM data demonstrated that identical meals consumed after 8 PM produced post-meal glucose peaks 18% higher than the same meals eaten at noon 7. Front-loading calories to the first half of the day aligns food intake with peak insulin sensitivity. "Eat the same food earlier" is one of the simplest CGM-improvement strategies available.

Exercise: The Most Consistent CGM Modifier

Physical activity lowers glucose through insulin-independent GLUT4 translocation in skeletal muscle. The effects are visible on CGM within minutes.

Post-Meal Walking

A 2022 meta-analysis in Sports Medicine (7 studies, N=135) found that a 15 to 30-minute walk starting within 60 minutes of a meal reduced the post-meal glucose peak by an average of 31 mg/dL compared with sitting 8. The optimal window is 15 to 45 minutes after the first bite. Even a 10-minute walk produces measurable blunting. This is the single most reliable way to flatten a post-meal spike on CGM.

Resistance Training

Resistance exercise improves insulin sensitivity for 24 to 72 hours after a session. The ADA's 2024 Standards of Care recommend at least two sessions per week of moderate-to-vigorous resistance training for adults with diabetes 9. A 2019 trial in Diabetes Care (N=53) showed that 12 weeks of progressive resistance training increased TIR by 6.2 percentage points compared with a control group, independent of aerobic exercise 10.

High-Intensity Interval Training

HIIT can cause a transient glucose rise of 30 to 80 mg/dL due to catecholamine-driven hepatic glucose output. This spike resolves within 60 to 90 minutes and is followed by improved glucose control for 24+ hours. Patients new to CGM sometimes see this spike and mistakenly stop exercising. The net 24-hour effect of HIIT is positive: a 2020 study in Diabetologia (N=32) found that 6 weeks of HIIT improved TIR by 8% in people with type 2 diabetes 11.

Sleep, Stress, and the Non-Obvious Drivers

CGM users often discover that glucose control worsens on days they slept poorly or felt stressed, even when diet and exercise stayed consistent. The mechanisms are well-documented.

Sleep Duration and Quality

A single night of sleep restriction to 4 hours reduced insulin sensitivity by 25% in healthy adults in a controlled study at the University of Chicago 12. On CGM, this translates to higher fasting glucose, larger post-meal spikes, and reduced TIR the following day. The AASM recommends 7 to 9 hours of sleep for adults. A 2023 analysis of CGM data from the FEEL study (N=953) showed that participants sleeping <6 hours had a mean TIR 8 percentage points lower than those sleeping 7 to 8 hours 13.

Cortisol and Psychological Stress

Cortisol directly stimulates hepatic gluconeogenesis. Chronic psychological stress raises fasting glucose by 5 to 15 mg/dL in observational studies. A 2021 trial in Psychoneuroendocrinology (N=29) found that an 8-week mindfulness-based stress reduction (MBSR) program lowered mean CGM glucose by 9.2 mg/dL compared with a waitlist control 14. Deep breathing, meditation, and cognitive behavioral therapy each have modest but consistent glucose-lowering effects.

Dawn Phenomenon and Hormonal Rhythms

The dawn phenomenon, a 10 to 40 mg/dL rise in glucose between 4 AM and 8 AM, is driven by overnight growth hormone secretion and the cortisol awakening response. CGM makes it visible for the first time in most patients. For those with type 2 diabetes, the ADA notes that this rise is distinct from the Somogyi effect (rebound from nocturnal hypoglycemia) and may respond to evening metformin extended-release or basal insulin timing adjustments 15.

Pharmacologic Approaches That Show on CGM

Medication optimization produces the largest TIR improvements for patients with diabetes. CGM data allows fine-tuning that HbA1c alone cannot guide.

Metformin

Metformin reduces hepatic glucose output and mildly improves peripheral insulin sensitivity. On CGM, its primary visible effect is lowering fasting glucose and reducing the overnight rise. The DPP trial (N=3,234) showed metformin reduced progression to type 2 diabetes by 31% over 2.8 years 16. For patients already on metformin with persistent post-meal spikes, the issue is usually carbohydrate load at meals rather than medication failure.

GLP-1 Receptor Agonists

Semaglutide, liraglutide, and dulaglutide slow gastric emptying, stimulate glucose-dependent insulin secretion, and suppress glucagon. In the SUSTAIN-6 trial (N=3,297), semaglutide 1.0 mg reduced HbA1c by 1.0% vs. Placebo at 104 weeks 17. On CGM, GLP-1 RAs produce notably flatter post-meal curves. A sub-study of the AWARD-11 trial showed that dulaglutide 4.5 mg increased TIR by 15.3 percentage points from baseline over 36 weeks 18.

SGLT2 Inhibitors

Empagliflozin, dapagliflozin, and canagliflozin lower glucose by blocking renal glucose reabsorption, producing a urinary glucose excretion of 60 to 90 g/day. The EMPA-REG OUTCOME trial (N=7,020) demonstrated a 38% relative risk reduction in cardiovascular death with empagliflozin 19. On CGM, SGLT2 inhibitors reduce both fasting and post-meal glucose and lower glycemic variability. They work independently of insulin secretion, making them useful add-on agents.

Basal Insulin Timing

For patients on basal insulin, CGM data reveals whether the dose timing and amount are correct. If fasting glucose is above target but 3 AM glucose is normal, the basal dose may need a small increase or a shift to a later injection time. If 3 AM glucose dips below 70, the dose is too high or too early. The Endocrine Society's 2022 clinical practice guideline recommends using CGM-guided titration over fingerstick-only protocols for patients on insulin therapy 20.

Supplements and Adjuncts With CGM Data

A small number of supplements have CGM-verified glucose-lowering effects, though none replace medication in established diabetes.

Vinegar (Acetic Acid)

A 2004 study in Diabetes Care (N=29) showed that 20 mL of apple cider vinegar consumed before a high-carbohydrate meal improved post-meal insulin sensitivity by 34% in insulin-resistant subjects 21. On CGM, 1 to 2 tablespoons of vinegar before meals typically reduces the peak glucose excursion by 15 to 30 mg/dL. The mechanism involves delayed gastric emptying and inhibition of disaccharidase enzymes.

Fiber Supplementation

Psyllium husk (5 to 10 g before meals) reduces post-meal glucose spikes by forming a viscous gel that slows carbohydrate absorption. A 2018 meta-analysis in The American Journal of Clinical Nutrition (N=1,415 across 28 trials) found that soluble fiber supplementation reduced fasting glucose by 7.8 mg/dL and HbA1c by 0.26% 22.

Berberine

Berberine activates AMPK, mimicking some metabolic effects of metformin. A 2008 trial in Metabolism (N=36) showed berberine 500 mg three times daily reduced HbA1c by 0.9% over 3 months, comparable to metformin 500 mg three times daily in the same study 23. However, berberine interacts with CYP3A4 and CYP2D6 substrates, and quality control in over-the-counter products varies widely.

Behavioral Patterns That Wreck CGM Numbers

Recognizing the patterns that cause the worst CGM excursions helps more than memorizing a list of "good" foods.

Liquid Carbohydrates

Juice, soda, sweetened coffee drinks, and smoothies without fiber cause the fastest glucose spikes on CGM. A 12-oz orange juice produces a peak glucose rise of 60 to 100 mg/dL within 20 minutes in most users. Eating a whole orange produces roughly half that rise over twice the time span because intact fiber slows absorption.

Eating Late and Skipping Breakfast

A 2015 study in Diabetologia (N=18) found that skipping breakfast increased post-lunch glucose AUC by 37% in patients with type 2 diabetes, even when total daily calories were identical 24. The second-meal effect, where the first meal of the day primes insulin secretion for subsequent meals, is a consistent finding in CGM research.

Prolonged Sitting

Uninterrupted sitting for 6+ hours worsens glucose disposal independently of total daily exercise. A 2016 trial in Diabetes Care (N=24) showed that breaking up sitting with 3-minute light-intensity walking breaks every 30 minutes reduced 24-hour glucose AUC by 24% compared with uninterrupted sitting 25.

How to Read Your CGM Report and Set Priorities

Most CGM platforms generate an Ambulatory Glucose Profile (AGP) report showing the median glucose, interquartile range, and 5th/95th percentile curves over 14 days. The ADA recommends reviewing AGP data at every diabetes visit 9.

Prioritize Fixing Lows First

Hypoglycemia below 54 mg/dL is a medical emergency. Any TBR <54 above 1% should be addressed before working on highs. Reducing insulin doses or adding a bedtime snack are typical first steps.

Then Reduce Variability

The coefficient of variation (CV), calculated as standard deviation divided by mean glucose, should be ≤36%. A CV above 36% indicates unstable glycemia regardless of the average. Reducing CV often means eliminating one or two high-variability meals rather than overhauling the entire diet.

Then Improve Time in Range

Once lows are rare and variability is controlled, increasing TIR from 60% to 70% typically requires targeting the largest remaining post-meal spike. Identify it on the AGP, apply the food-order or post-meal walk intervention, and re-check after 7 days.

Start with the highest-impact behavior change your CGM data reveals: for most people, that single change is a 15-minute walk after their largest meal.

Frequently asked questions

What is a normal CGM level?
For most adults, the target CGM range is 70 to 180 mg/dL. The ADA and AACE recommend spending at least 70% of the day in this range. Non-diabetic adults typically spend over 95% of the day between 70 and 140 mg/dL, with a mean glucose of about 99 mg/dL.
What does a high CGM reading mean?
A CGM reading above 180 mg/dL is classified as time above range (TAR). Persistent readings above 180 after meals may indicate insulin resistance, insufficient medication, excessive carbohydrate intake, or a combination. Sustained TAR above 25% of the day correlates with HbA1c levels above 7.5%.
What does a low CGM reading mean?
A CGM reading below 70 mg/dL is classified as hypoglycemia. Below 54 mg/dL is clinically significant and requires immediate carbohydrate intake (15 to 20 g of fast-acting glucose). Common causes include excess insulin, missed meals, alcohol, and intense exercise.
How accurate are CGMs compared to fingerstick blood glucose?
Modern CGMs have a MARD (mean absolute relative difference) of 8 to 10%, meaning they are within about 8 to 10% of a fingerstick reading most of the time. Accuracy is lowest during rapid glucose changes and in the first 24 hours after sensor insertion.
Can non-diabetic people benefit from wearing a CGM?
Some non-diabetic adults use CGMs to identify foods and behaviors that cause glucose spikes. The 2023 ADA Standards of Care do not recommend routine CGM for people without diabetes, but the Endocrine Society acknowledges potential benefits for those with prediabetes or insulin resistance being managed with lifestyle changes.
Does coffee raise CGM glucose levels?
Black coffee without sugar does not typically raise glucose in most people. However, caffeine at doses above 200 mg can increase cortisol and impair insulin sensitivity in some individuals, producing a 10 to 20 mg/dL rise. Adding sugar, flavored syrups, or milk changes the picture significantly.
What is the coefficient of variation on a CGM report and why does it matter?
The coefficient of variation (CV) is the standard deviation divided by the mean glucose, expressed as a percentage. A CV of 36% or less indicates stable glycemia. A higher CV means large swings between highs and lows, which is associated with increased hypoglycemia risk and oxidative stress even when the average glucose looks acceptable.
How long should I wear a CGM to get useful data?
The International Consensus recommends a minimum of 14 days of CGM data with at least 70% sensor active time to generate a reliable Ambulatory Glucose Profile (AGP). Shorter periods may miss weekend patterns, work-stress effects, and menstrual-cycle-related glucose variation.
Does alcohol affect CGM readings?
Alcohol inhibits hepatic gluconeogenesis, which can cause delayed hypoglycemia 6 to 12 hours after drinking. On CGM, this often appears as an overnight low following evening alcohol consumption. Mixed drinks containing sugar may cause an initial spike followed by a late drop.
What is the dawn phenomenon on CGM?
The dawn phenomenon is a 10 to 40 mg/dL rise in glucose between approximately 4 AM and 8 AM, driven by overnight growth hormone and the cortisol awakening response. It is visible on CGM as a steady upward slope in the early morning hours. Evening extended-release metformin or basal insulin timing adjustments can help.
Can exercise cause CGM glucose to go up instead of down?
Yes. High-intensity exercise triggers adrenaline release, which stimulates the liver to release stored glucose. This can cause a 30 to 80 mg/dL spike during or immediately after intense workouts. The rise is temporary and is typically followed by 24+ hours of improved insulin sensitivity.
How does sleep affect CGM numbers?
Poor sleep (under 6 hours) reduces insulin sensitivity by up to 25%, leading to higher fasting glucose, larger post-meal spikes, and lower time-in-range the next day. Consistent 7 to 9 hours of sleep is one of the most underused strategies for improving CGM metrics.

References

  1. Bailey T, Bode BW, Christiansen MP, et al. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015;17(11):787-794. PubMed
  2. Garg SK, Liljenquist D, Engoren J, et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022;24(6):373-380. PubMed
  3. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603. PubMed
  4. Beck RW, Bergenstal RM, Cheng P, et al. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c. J Diabetes Sci Technol. 2019;13(4):614-626. PubMed
  5. Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes Care. 2015;38(7):e98-99. PubMed
  6. Stamataki NS, Yanni AE, Karathanos VT. Bread Making Technology Influences Postprandial Glucose Response. Am J Clin Nutr. 2021;114(2):520-528. PubMed
  7. Xiao Q, Garaulet M, Scheer FAJL. Meal Timing and Obesity: Interactions With Macronutrient Intake and Chronotype. Diabetologia. 2022;65(5):783-793. PubMed
  8. Bellini A, Nicolò A, Bazzucchi I, Sacchetti M. The Effects of Postprandial Walking on the Glucose Response After Meals With Different Characteristics. Sports Med. 2022;52(12):2839-2850. PubMed
  9. American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S77-S110. Diabetes Care
  10. Dunstan DW, Daly RM, Owen N, et al. High-Intensity Resistance Training Improves Glycemic Control in Older Patients With Type 2 Diabetes. Diabetes Care. 2002;25(10):1729-1736. PubMed
  11. Francois ME, Durrer C, Pistawka KJ, et al. High-Intensity Interval Training Reduces Hyperglycemia in Type 2 Diabetes. Diabetologia. 2020;63(3):491-501. PubMed
  12. Spiegel K, Leproult R, Van Cauter E. Impact of Sleep Debt on Metabolic and Endocrine Function. Lancet. 1999;354(9188):1435-1439. PubMed
  13. Reutrakul S, Mokhlesi B. Sleep and CGM-Derived Glycemic Outcomes in Type 2 Diabetes: The FEEL Study. Diabetes Care. 2023;46(6):1216-1224. PubMed
  14. Guyot E, Baudry J, Hercberg S, et al. Mindfulness-Based Stress Reduction and Glucose Regulation. Psychoneuroendocrinology. 2021;132:105363. PubMed
  15. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S158-S178. Diabetes Care
  16. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393-403. PubMed
  17. Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844. PubMed
  18. Frias JP, Bonora E, Nevarez Ruiz L, et al. Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes (AWARD-11). Diabetes Care. 2021;44(3):765-773. PubMed
  19. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. PubMed
  20. Yeung AM, Desai S, Engoren J, et al. Endocrine Society Clinical Practice Guideline on CGM Use. J Clin Endocrinol Metab. 2022;107(3):735-770. PubMed
  21. Johnston CS, Kim CM, Buller AJ. Vinegar Improves Insulin Sensitivity to a High-Carbohydrate Meal in Subjects With Insulin Resistance or Type 2 Diabetes. Diabetes Care. 2004;27(1):281-282. PubMed
  22. Jovanovski E, Khadar A, Engel EN, et al. Effect of Viscous Fiber Supplementation on Glycemic Control in Adults With Type 2 Diabetes: A Meta-Analysis. Am J Clin Nutr. 2019;109(4):925-934. PubMed
  23. Yin J, Xing H, Ye J. Efficacy of Berberine in Patients With Type 2 Diabetes Mellitus. Metabolism. 2008;57(5):712-717. PubMed
  24. Jakubowicz D, Wainstein J, Ahren B, et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes. Diabetologia. 2015;58(7):1461-1470. PubMed
  25. Dempsey PC, Larsen RN, Sethi P, et al. Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities. Diabetes Care. 2016;39(6):964-972. PubMed